文献速递心境障碍

重度抑郁症脑结构与功能偏差的量化:跨神经影像模态研究

Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities.
PubMed 文献 · JAMA Psychiatry · 2022-01-01

该横断面病例对照研究纳入1809人(861例MDD患者,948名健康对照),比较结构MRI、弥散张量成像及任务态和静息态功能MRI的单变量效应量、分类准确性和分布重叠。结果显示最大单变量效应量偏η²为0.004至0.017,分布重叠87%至95%,分类准确性54%至56%,与多基因风险评分相当但远小于环境变量。

要点

  • 最大单变量组间差异的偏η²为0.004至0.017,分布重叠87%至95%。
  • 各神经影像模态的分类准确性为54%至56%,单被试预测不可行。
  • 差异与多基因风险评分相当,但远小于环境变量。

核心结论

  • 即使最大单变量生物学差异,MDD患者与健康对照的偏差也极小,组间相似性占主导,单被试预测不可行。

研究设计与样本

  • 横断面病例对照临床神经影像研究,数据来自德国马尔堡-明斯特情感障碍队列研究,2014年9月11日至2018年9月26日招募18至65岁急性和慢性MDD患者及健康对照。

主要发现

  • 共纳入1809人(861例患者[47.6%],948名对照[52.4%]),平均年龄35.6岁(SD 13.2),女性1165例(64.4%)。
  • 最大单变量组间差异的偏η²为0.004至0.017,分布重叠87%至95%,分类准确性54%至56%。
  • 仅分析急性或慢性抑郁患者时,该模式几乎不变。
  • 差异与多基因风险评分相当,但远小于环境变量。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Identifying neurobiological differences between patients with major depressive disorder (MDD) and healthy individuals has been a mainstay of clinical neuroscience for decades. However, recent meta-analyses have raised concerns regarding the replicability and clinical relevance of brain alterations in depression. OBJECTIVE: To quantify the upper bounds of univariate effect sizes, estimated predictive utility, and distributional dissimilarity of healthy individuals and those with depression across structural magnetic resonance imaging (MRI), diffusion-tensor imaging, and functional task-based as well as resting-state MRI, and to compare results with an MDD polygenic risk score (PRS) and environmental variables. DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional, case-control clinical neuroimaging study. Data were part of the Marburg-Münster Affective Disorders Cohort Study. Patients with depression and healthy controls were recruited from primary care and the general population in Münster and Marburg, Germany. Study recruitment was performed from September 11, 2014, to September 26, 2018. The sample comprised patients with acute and chronic MDD as well as healthy controls in the age range of 18 to 65 years. Data were analyzed from October 29, 2020, to April 7, 2022. MAIN OUTCOMES AND MEASURES: Primary analyses included univariate partial effect size (η2), classification accuracy, and distributional overlapping coefficient for healthy individuals and those with depression across neuroimaging modalities, controlling for age, sex, and additional modality-specific confounding variables. Secondary analyses included patient subgroups for acute or chronic depressive status. RESULTS: A total of 1809 individuals (861 patients [47.6%] and 948 controls [52.4%]) were included in the analysis (mean [SD] age, 35.6 [13.2] years; 1165 female patients [64.4%]). The upper bound of the effect sizes of the single univariate measures displaying the largest group difference ranged from partial η2 of 0.004 to 0.017, and distributions overlapped between 87% and 95%, with classification accuracies ranging between 54% and 56% across neuroimaging modalities. This pattern remained virtually unchanged when considering either only patients with acute or chronic depression. Differences were comparable with those found for PRS but substantially smaller than for environmental variables. CONCLUSIONS AND RELEVANCE: Results of this case-control study suggest that even for maximum univariate biological differences, deviations between patients with MDD and healthy controls were remarkably small, single-participant prediction was not possible, and similarity between study groups dominated. Biological psychiatry should facilitate meaningful outcome measures or predictive approaches to increase the potential for a personalization of the clinical practice.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Winter NR, Leenings R, Ernsting J, et al. Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities. JAMA Psychiatry. 2022. PMID: 35895072. doi:10.1001/jamapsychiatry.2022.1780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。